Skip to main content

23 June 2026

Last updated: Monday 22 June 2026

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

How Cellectis developed gene editing for cancer

Sunday 10 July 2016

Interviewee/Contributor

André Choulika

Organisation

Cellectis SA

Organisations

Zelluna Immunotherapy AS
Medherant Ltd
London Business School
Pelago Bioscience AB
Eli Lilly and Company
Innovative Medicines Initiative (IMI)
Index Ventures Management LLP
Argenx NV
Ethris GmbH
MedNous editorial board member

Interviewees and Contributers

Jackie Turnbull and David Bates
Malcolm Weir
Greg Mullen
Simon Kerry
Stefan Larsson
Reinhard Kandera
Roel Bulthuis
Walter Schmidt
Alexander Natz et al
Dominique Costantini

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Evotec names head of in silico and AI

Saturday 20 June 2026

Forbion promotes senior officers, appoints operating partner

Saturday 20 June 2026

Specialist CDMO Ardena appoints CSO

Saturday 20 June 2026

CellaVision names CEO

Saturday 20 June 2026

FundaMental Pharma names CMO to lead depression candidate

Saturday 20 June 2026

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2026 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form